Two Pandemics Coalition: Covid-19 and Obesity

1. WHO characterizes COVID-19 as a pandemic. (11 March 2020); Available from: https://www.who.int/emergencies/diseases/novelcoronavirus-2019/events-as-they-happen. WHO Director-General’s opening remarks at the media briefing on COVID-19 - 11 March 2020. (23 March 2020); Available from: https://www.who.int/dg/speeches/detail/who-director-general-sopening-remarks-at-the-media-briefing-oncovid-19%2D%2D-11-march-2020)Search in Google Scholar

2. GuanWJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020 Feb;28 EpubSearch in Google Scholar

3. Caspard H, Jabbour S, Hammar N, Fenici P, Sheehan JJ, Kosiborod M (2018) Recent trends in the prevalence of type 2 diabetes and the association with abdominal obesity lead to growing health disparities in the USA: an analysis of the NHANES surveys from 1999 to 2014. Diabetes Obes Metab 20(3):667–6710.1111/dom.13143583692329077244Search in Google Scholar

4. Roser M, Ritchie H, Ortiz-Ospina E, Coronavirus Disease (COVID-19). Research and Statistics. University of Oxford, 2020Search in Google Scholar

5. Puig-Domingo M, Marazuela M, Giustina A. COVID-19 and endocrine diseases. A statement from the European Society of Endocrinology. Endocrine. 2020;68(1):2–5. doi:10.1007/s12020-020-02294-5).Search in Google Scholar

6. S. Popa, M. Mo a, A. Popa et al; “ Prevalence of overweight/obesity, abdominal obesity and metabolic syndrom and atypical cardiometabolic phenotypes in the adult Romanian population: Predatorr study, J. Endocrinol.Invest. Springer, published online 28th of April 201610.1007/s40618-016-0470-427126310Search in Google Scholar

7. Sideleva O, Suratt BT, Black KE, et al. Obesity and asthma: an inflammatory disease of adipose tissue not the airway. American journal of respiratory and critical care medicine 2012 10 1;186(7):598–60510.1164/rccm.201203-0573OC348052222837379Search in Google Scholar

8. Polotsky VY, Smaldone MC, Scharf MT, et al. Impact of interrupted leptin pathways on ventilatory control. J Appl Physiol (1985) 2004 3;96(3):991–8. doi: 10.1152/japplphysiol.00926.2003. (PubMed: 14578371)10.1152/japplphysiol.00926.200314578371Search in Google Scholar

9. Bassi M, Furuya WI, Menani JV, et al. Leptin into the ventrolateral medulla facilitates chemorespiratory response in leptin-deficient (ob/ob) mice. Acta Physiol (Oxf) 2014 5;211(1):240–8. doi: 10.1111/apha.12257. (PubMed: 24521430)10.1111/apha.12257436578324521430Search in Google Scholar

10. L. F, C. J, A. H, et al. Obesity is associated with higher risk of intensive care unit admission and death in influenza A (H1N1) patients: a systematic review and meta-analysis. Obesity Reviews 2011;12(8):653–659. doi: doi:10.1111/j.1467-789X.2011.00864.x. (PubMed: 21457180)10.1111/j.1467-789X.2011.00864.x21457180Search in Google Scholar

11. Ubags ND, Stapleton RD, Vernooy JH, et al. Hyperleptinemia is associated with impaired pulmonary host defense. JCI Insight 2016 6;1(8). doi: 10.1172/jci.insight.82101.10.1172/jci.insight.82101491685427347561Search in Google Scholar

12. Shah D, Romero F, Duong M, et al. Obesity-induced adipokine imbalance impairs mouse pulmonary vascular endothelial function and primes the lung for injury. Sci Rep 2015 6;5:11362. doi: 10.1038/srep11362. (PubMed: 26068229)10.1038/srep11362446432326068229Search in Google Scholar

13. Agrawal A, Mabalirajan U, Ahmad T, et al. Emerging interface between metabolic syndrome and asthma. Am J Respir Cell Mol Biol 2011 3;44(3):270–5. doi: 10.1165/rcmb.2010-0141TR. (PubMed: 20656947)10.1165/rcmb.2010-0141TR20656947Search in Google Scholar

14. Zaigham S, Nilsson PM, Wollmer P, et al. The temporal relationship between poor lung function and the risk of diabetes. BMC Pulm Med 2016 5;16(1):75. doi: 10.1186/s12890-016-0227-z. (PubMed: 27165091)10.1186/s12890-016-0227-z486335827165091Search in Google Scholar

15. Brittain EL, Nwabuo C, Xu M, et al. Echocardiographic Pulmonary Artery Systolic Pressure in the Coronary Artery Risk Development in Young Adults (CARDIA) Study: Associations With Race and Metabolic Dysregulation. J Am Heart Assoc 2017 3;6(4). doi: 10.1161/JAHA.116.005111.10.1161/JAHA.116.005111553301328360228Search in Google Scholar

16. Ford ES, Cunningham TJ, Mercado CI. Lung function and metabolic syndrome: Findings of National Health and Nutrition Examination Survey 2007–2010. J Diabetes 2014 11;6(6):603–13. (PubMed: 26677470)10.1111/1753-0407.12136468494026677470Search in Google Scholar

17. Gabriela P. Peralta GP, et al. Body mass index and weight change are associated with adult lung function trajectories: the prospective ECRHS studyThorax 2020Search in Google Scholar

18. 18.Weisberg SP, McCann D, Desai M, et al. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003 12;112(12):1796–808. doi: 10.1172/JCI19246. (PubMed: 14679176)10.1172/JCI1924629699514679176Search in Google Scholar

19. Periyalil HA, Wood LG, Wright TA, et al. Obese asthmatics are characterized by altered adipose tissue macrophage activation. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 2018 1 31. doi: 10.1111/cea.1310910.1111/cea.1310929383778Search in Google Scholar

20. Puig-Domingo M, Marazuela M, Giustina A. COVID-19 and endocrine diseases. A statement from the European Society of Endocrinology. Endocrine. 2020;68(1):2–5.10.1007/s12020-020-02294-5715052932279224Search in Google Scholar

21. Anderson CJ, Murphy KE, Fernandez ML, Impact of obesity and metabolic syndrome on immunity. Adv Nutr 2016, 7:66–77.10.3945/an.115.010207471789026773015Search in Google Scholar

22. Ouchi N, Parker JL, Lugus JJ, Walsh K,Adipokines in inflammation and metabolic disease. Nat Rev Immunol, 2011,11(2):85–97.10.1038/nri2921351803121252989Search in Google Scholar

23. Richard C, Wadowski M, Goruk S et al (2017) Individuals with obesity and type 2 diabetes have additional immune dysfunction compared with obese individuals who are metabolically healthy. BMJ Open Diabetes Res Care 5(1)10.1136/bmjdrc-2016-000379553025228761653Search in Google Scholar

24. Ahn SY, Sohn SH, Lee SY et al, The effect of lipopolysaccharide-induced obesity and its chronic inflammation on influenza virus-related pathology. Environ Toxicol Pharmacol, 2015,40(3):924–93010.1016/j.etap.2015.09.02026509733Search in Google Scholar

25. Xue K, Stevens-Ayers T, Campbell AP et al, Parallel evolution of influenza across multiple spatiotemporal scales, 2017, eLife 2017;6:e2687510.7554/eLife.26875548720828653624Search in Google Scholar

26. Zheng Q, Cui G, Chen J et al, Regular exercise enhances the immune response against microbial antigens through upregulation of toll-like receptor signaling pathways. Cell Physiol Biochem 37:735–746), 201510.1159/000430391Search in Google Scholar

27. Luzi L.,Radaelli M.G.- Influenza and obesity: its odd relationship and the lessons for COVID 19 pandemic-Acta Diabetologica https://doi.org/10.1007/s00592-020-01522-8)Search in Google Scholar

28. Maier H, Lopez R, Sanchez N et al, Obesity increased the duration of influenza A virus shedding in adults. J Infect Dis 2018, 218(9):1372–138210.1093/infdis/jiy370Search in Google Scholar

29. Klinkhammer J, Schnepf D, Ye L et al, INF-lambda prevents influenza virus spread from the upper airways to the lungs and limits virus transmission 2018, elife 7:e3335410.7554/eLife.33354Search in Google Scholar

30. Yan J, Grantham M, Pantelic J et al, Incetious virus in exhaled breath of syntomatic seasonal influenza cases from a college community, 2018, PNAS 115(5):1081–1086)10.1073/pnas.1716561115Search in Google Scholar

31. Donna H. Ryan, Eric Ravussin, and Steven Heymsfield COVID 19 and the Patient with Obesity – The Editors Speak Out The Obesity Society. Published online 1 April 2020. 2020 Apr 9. doi: 10.1002/oby.22831. (Epub ahead of print)10.1002/oby.22831Search in Google Scholar

32. Jennifer Lighter, Michael Phillips, Sarah Hochman, Stephanie Sterling, Diane Johnson, Fritz Francois, Anna Stachel, Obesity in patients younger than 60 years is a risk factor for Covid-19 hospital admission Published by Oxford University Press for the Infectious Diseases Society of America, April 10, 202010.1093/cid/ciaa415Search in Google Scholar

33. Simonnet A, Chetboun M, Poissy J, Raverdy V, Noulette J, Duhamel A, Labreuche J, Mathieu D, Pattou F, Jourdain M; Lille Intensive Care COVID-19 and Obesity study group, High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation, Obesity ( Silver Spring ) 2020 April 9.10.1002/oby.22831Search in Google Scholar

34. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet 2020;395:1054–1062.10.1016/S0140-6736(20)30566-3Search in Google Scholar

35. Kerkhove MDV, Vandemaele KAH, Shinde V, et al. Risk Factors for Severe Outcomes following 2009 Influenza A (H1N1) Infection: A Global Pooled Analysis. PLOS Medicine 2011;8:e100105310.1371/journal.pmed.1001053313002121750667Search in Google Scholar

36. Handbook of COVID-19 Prevention and Treatment, Compiled According to Clinical Experience, The First Affiliated Hospital, Zhejiang University School of Medicine, 2020Search in Google Scholar

37. William B Grant, Henry Lahore et al, Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths, Nutrients, April 2020Search in Google Scholar

38. Anna Vittoria Mattioli, MD, PhD, and Matteo Ballerini Puviani, MSc Lifestyle at Time of COVID-19: How Could Quarantine Affect Cardiovascular Risk, American Journal of lifestyle medicine, April 2020, vol XX, noX10.1177/1559827620918808723289732477021Search in Google Scholar